(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of EGFR for use in the treatment of brain tumors

AU2026208134A1Pending Publication Date: 2026-08-13DANA FARBER CANCER INSTITUTE INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-07-27
Publication Date
2026-08-13

Smart Images

  • Figure 00000156_0000
    Figure 00000156_0000
  • Figure 00000157_0000
    Figure 00000157_0000
  • Figure 00000157_0001
    Figure 00000157_0001
Patent Text Reader

Abstract

20 26 20 81 34 27 J ul 2 02 6 A B S T R A C T 2 0 2 6 2 0 8 1 3 4 2 7 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art